Skip to content

Daily Subjective and Objective Smartphone Measures of Illness Activity to Treat Bipolar Disorder- The MONARCA II Trial

Daily Electronic Monitoring of Subjective and Objective Measures of Illness Activity in Bipolar Disorder - The MONARCA II Trial (MONitoring, treAtment and pRediCtion of bipolAr Disorder Episodes II)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02221336
Acronym
MONARCAII
Enrollment
146
Registered
2014-08-20
Start date
2014-09-30
Completion date
2018-01-31
Last updated
2018-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder

Keywords

Bipolar disorder, Daily electronic monitoring, Smartphones, Subjective and objective smartphone data, Feedback loop

Brief summary

Bipolar disorder is associated with a high risk of relapse and hospitalisation and many patients do not recover to their previous psychosocial function. Major reasons for poor outcomes are delayed intervention for prodromal depressive and manic symptoms as well as decreased adherence with treatment. Recently, in the MONARCA I trial (NCT01446406), the investigators developed and deployed a smartphone based self-monitoring system (the MONARCA I system) in a randomized controlled trial, to test the effect of daily reporting of subjective self-monitoring of depressive and manic symptoms as well as a bi-directional feedback loop on depressive and manic symptoms. In the MONARCA II trial the investigators will develop and deploy a new version of the smartphone based monitoring system. The investigators will in a randomized controlled single blind trial investigate whether daily electronic monitoring of subjective and objective measures of illness activity using a smartphone based self-monitoring system including feedback on subjective as well as automatically generated objective data (e.g.social activity, physical activity etc.) (the MONARCA II system) reduces the severity of depressive and manic symptoms and improves functioning more than a control group receiving a smartphone. All patients will be followed for 9 months with outcome assessments at baseline, after 4 weeks, after 3 months, after 6 months and after 9 months.

Interventions

DEVICEThe MONARCA II system

Daily electronic monitoring of subjective and objective smartphone measures including a feedback loop

DEVICENon-MONARCA II system

Daily use of smartphone for normal communicative purposes. No self-monitoring in the MONARCA II system.

Sponsors

University of Copenhagen
CollaboratorOTHER
IT University of Copenhagen
CollaboratorOTHER
Psychiatric Centre Rigshospitalet
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Bipolar Disorder according to SCAN interview * ≥18 years of age * Patients who previously have received a course of treatment at the Clinic for Affective Disorders, Psychiatric Centre Copenhagen, Denmark

Exclusion criteria

* Pregnancy * Lack of Danish language skills * Patients who previously have received and used the MONARCA I system for self-monitoring

Design outcomes

Primary

MeasureTime frameDescription
Differences between the groups in depressive and manic symptoms and the number of affective episodesBaseline and up to 9 monthsDifferences between the groups in depressive and manic symptoms measured using Hamilton Depression Rating Scale (HDRS) and Young Mania Rating Scale (YMRS) and episodes defined ad HDRS\<= 14 and/or YMRS\<= 14

Secondary

MeasureTime frameDescription
Differences between the groups in number of hospitalizationsBaseline up to 9 months follow upDifferences between the groups in number of hospitalization
Differences between the groups in number of contacts to clinicians and emergency roomsBaseline up to 9 months follow upDifferences between the groups in number of contacts to clinicians and emergency rooms
Differences between the groups in functioningBaseline up to 9 months follow upDifferences between the groups in functioning measured using the FAST questionnaire
Differences between the groups in perceived stressBaseline up to 9 monthsDifferences between the groups in perceived stress using the perceived stress questionnaire
Differences between the groups in quality of lifeBaseline up to 9 months follow upDifferences between the groups in quality of life measured using the WHOQoL questionnaire
Differences between the groups in smartphone measuresBaseline and up to 9 monthsDifferences between the groups in: -Automatically generated objective smartphone measures
Differences in self-rated manic symptomsBaseline up to 9 months follow upDifferences between the groups in self-rated manic symptoms using the ASRM questionnaire
Differences between the groups in adherence to medicationBaseline up to 9 months follow upDifferences between the groups in adherence to medication measured using the questionnaire MARS
Differences between the groups in recoveryBaseline up to 9 months follow upDifferences between the groups in recovery using the questionnaire Recovery Assessment Scale (RAS)
Differences between the groups in empowermentbaseline up ot 9 monthsDifferences between the groups in empowerment using the questionnaire Rogers Empowerment scale.
Differences between the groups in self-rated depressive symptomsBaseline up to 9 monthsDifferences between the groups in self-rated depresisve symptoms using the BDI questionnaire

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026